Health · 2 views
Antibody screening approach could speed development of immune-based cancer treatments
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.
Summary
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies. In a study published in Nature Communications , the team used the new approach to create an investigational treatment that showed strong activity against aggressive B-cell lymphomas in laboratory experiments.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Greater contact with nature linked to a more positive relationship with foodContinue reading
- Hit a midlife wall? This test identifies your strengths and what matters to youContinue reading
- Study finds prebiotic fiber helps girls build more boneContinue reading
- Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine successContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow